Nurix Therapeutics, Inc. · NASDAQ:NRIX

van Houte Hans sold 4,761 Nurix Therapeutics, Inc. shares (Form 4)

Traded Aug 4, 2026 · Filed Aug 4, 2026

On Aug 4, 2026, van Houte Hans (Chief Financial Officer) sold 4,761 Nurix Therapeutics, Inc. shares at an average US$24.36 for US$116K under a trading plan, leaving 40,166 shares. Filed Aug 4, 2026 (Form 4).

Sold
4,761 shares
Price
US$24.36 average (US$23.89 to US$24.65)
Value
US$116K
Holding after
40,166 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 4, 2026Common StockSale1,794US$23.8943,133Direct
Aug 4, 2026Common StockSale2,967US$24.6540,166Direct

Source

View original at SEC

Related